
XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Independent Study Shows Moderate Dose Strength of XORLO™ Attenuates Kidney Expansion […]
Independent Study Shows Moderate Dose Strength of XORLO™ Attenuates Kidney Expansion […]
The flagship 3D mapping catheter from Acutus Medical has been certified under the new European Medical Device Regulations […]
EDISON, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) — Zerify Inc. (OTCQB: ZRFY), the 21-year-old cyber security company focused on secure video conferencing solutions, is pleased to announce that Hollaway Consulting Engineers LLC., has licensed Zerify Defender […]
Interview with Evan Gappelberg, CEO
[…]
Interview with Dwain Morris-Irvin, CEO
[…]
EDISON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) — Zerify Inc. (OTCQB: ZRFY), the 21-year-old cyber security company focused on secure video conferencing solutions, is pleased to announce that Nepenthe Wellness Center has chosen Zerify Meet as […]
CARLSBAD, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards […]
There is no excerpt because this is a protected post.
Interview update with Larry Heaton, CEO and President […]
XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com